Financials
- Market Capitalization 11.6 M
- Employee 113
- Founded 2001
- CEO Yaky Yanay
- Website www.pluri-biotech.com
- Headquarter Nevada, United States
- FIGI BBG000DQX509
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.86
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4626 | PASG Passage Bio, Inc. - Common Stock | 3.64 USD | -20.00% | -9.45% | -22.55% | -58.82% | 11.71 M USD | ||
| 4629 | INAB IN8bio, Inc. - Common Stock | 1.18 USD | -4.07% | -14.49% | +8.26% | -29.34% | 11.63 M USD | ||
| 4631 | INTS Intensity Therapeutics, Inc. - Common Stock | 3.55 USD | +7.25% | +2.31% | -10.13% | +1167.86% | 11.59 M USD | ||
| 4632 | ASBP Aspire Biopharma Holdings, Inc. - Common Stock | 8.22 USD | +5.66% | -5.95% | -5.41% | +426.92% | 11.53 M USD |